Nasal polyps as possible target to achieve the best biological treatment choice in severe asthma

Nasal polyposis (NS) is one of the most impacting comorbidity on severe asthma (SA) control. A biological targeted therapy for SA might consider NP response. We evaluated in a large cohort of SA patients the main features related to NP severity aiming to achieve the best therapeutic choice. We enrolled 100 patients with SA. We recorded clinical and demographic data, particularly atopic features (skin prick test positivity, specific serum IgE,...